ID: MRFR/MED/1546-CR | May 2019 | Region: Global | 106 pages
The Global Lancet Market Registered a CAGR of 10.50% during the assessment period, with a market value of USD 1,595.5 Million in 2018.
Lancets are being used for diabetes/glucose test, tests in infants, heel-stick screening tests, as well as for scarred emergency patients or severely burned patients. The factors driving the market growth include growing incidence rate of contagious and non-contagious diseases, increasing prevalence of diabetes, and rising inclination towards home care and home diagnostics. However, the risk associated with blood transfusion is expected to hinder the market growth during the forecast period.
One of the major applications or functioning areas of lancets is to monitor diabetes in the diabetic population. According to the Centers for Disease Control and Prevention (CDC), 9.4% of the US population are diabetic patients. With the increasing prevalence of diabetes, the demand for lancets is expected to be enormous, thus resulting in the increasing demand for devices and products to monitor and control diabetes, eventually leading to increased use of lancets.
Global Lancet Market Revenue, by End User (USD Million)
Source: MRFR Analysis
The global lancet market based on type has been segmented into safety lancet and personal lancet. Safety lancets can be further divided into push-button safety lancets; pressure activated safety lancets and side button safety lancets. Based on end user, the market is segmented into the hospitals & clinics, diagnostic centers & pathology laboratories, home diagnostics, research and academic laboratories, and others. The hospitals & clinics segment held a major share with a market value of USD 544 Million in 2018.
The prominent players in the global lancet market are Terumo Corporation (Japan), Bayer AG (Germany), HTL-STREFA S.A. (Poland), Sarstedt AG & Co. (Germany), Becton, Dickinson and Company (US), Abbott Laboratories (US), F. Hoffmann-La Roche Ltd (Switzerland), Greiner Bio-One International GmbH (US), Improve Medical Instruments Co. Ltd (US) and others.
Some of the key strategies followed by players operating in the global lancet market were innovation, product development, acquisition, and mergers.
Global Lancet Market Share, 2018 (%)
Source: MRFR Analysis
The global lancet market, based on region, is divided into Europe, the Americas, Asia-Pacific, and the Middle East and Africa.
Europe held the largest share of the global lancet market. The Europe market demonstrated substantial growth in the market due to the growing demand and need for safe blood glucose tests in hospitals, clinics, diagnostics centers, etc. and the growth in insulin users. The Americas held a substantial share in the global lancet market owing to the rise in the prevalence of diabetes and the increasing need for a diabetes diagnosis. Asia-Pacific was the fastest growing region in the global market and accounted for 19.1% market share in the global market in 2018. The growth in this region is attributed to the low manufacturing cost and low labor cost in the region. Moreover, the Middle East and Africa showed the least growth owing to low per capita income and lack of adequate healthcare spending.
Global Lancet Market, by Type
Global Lancet Market, by End User
Global Lancet Market, by Region
Available Additional Customizations
Frequently Asked Questions (FAQ) :
Lancet Market valuation was USD 1595.5 million in 2018.
The projected CAGR would be USD 1595.5 million during the forecast period.
Risk regarding the blood transfusion process can prevent the market from having regular growth.
The hospitals and clinics segment would dominate.
Europe would enjoy the largest market share.